Molecular Variants Associated With Schizophrenia: Differential Analysis of Monozygotic Twins With Variable Phenotypic 22q11
NCT ID: NCT04141540
Last Updated: 2021-02-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
2 participants
INTERVENTIONAL
2020-03-27
2020-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Velocardiofacial (VCFS; 22q11.2; DiGeorge) Syndrome Study
NCT00105274
Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome
NCT00556530
Genetics and Psychopathology in the 22q11 Deletion Syndrome
NCT00161109
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
NCT01149551
Molecular Genetics of Schizophrenia
NCT00006418
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Groupe "Twin 1"
Twin 1 with psychotic symptoms (PANSS +) Molecular analyses 1
Molecular analyses
Comparaison of the molecular profil between two monozygotic twins carrying a deletion 22q11.2
Groupe "Twin 2"
Twin 2 without psychotic symptoms (PANSS +) Molecular analyses 2
Molecular analyses
Comparaison of the molecular profil between two monozygotic twins carrying a deletion 22q11.2
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Molecular analyses
Comparaison of the molecular profil between two monozygotic twins carrying a deletion 22q11.2
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
45 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hôpital le Vinatier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
DEMILY CAROLINE, MD PH.D
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier le Vinatier & CNRS UMR 5229 (BRON, France)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hopital Vinatier
Lyon, Auvergne-Rhône-Alpes, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-A00852-55
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.